Skip to main content
. 2004 Nov 23;4:83. doi: 10.1186/1471-2407-4-83

Figure 4.

Figure 4

Tumour growth inhibition by gefitinib vs. treosulfan + gefitinib in 2 different tumour types. Legend Figure 4a shows the positive effect of combining treosulfan plus gefitinib in cells derived from a skin melanoma compared with figure 4b in which the combination of treosulfan plus gefitinib has a negative effect in cells derived from an ovarian tumour.